Skip to search.
 FTSE 100 Up 0.62%
Streaming
Ticker Tape: On

TrovaGene, Inc. (TROV)

-NasdaqCM
4.85 Down 0.16(3.19%) 17 Apr 21:00
Add to Portfolio
Prev Close:5.01
Open:4.98
Bid:4.82 x 100
Ask:4.85 x 900
1y Target Est:10.00
Beta:-2.06
Next Earnings Date:N/A
Day's Range:4.82 - 5.02
52wk Range:4.02 - 10.27
Volume:41,629
Avg Vol (3m):61,581
Market Cap:91.67m
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for TROV at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):365.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.76
Quarterly EPS Est (Mar-14) :-0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback